MEZZASOMA, Anna Maria
 Distribuzione geografica
Continente #
NA - Nord America 742
EU - Europa 522
AS - Asia 305
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.574
Nazione #
US - Stati Uniti d'America 739
IE - Irlanda 166
SG - Singapore 107
UA - Ucraina 101
HK - Hong Kong 92
IT - Italia 88
CN - Cina 52
DE - Germania 32
VN - Vietnam 28
SE - Svezia 27
FI - Finlandia 26
RU - Federazione Russa 26
GB - Regno Unito 12
KR - Corea 12
ES - Italia 9
CZ - Repubblica Ceca 7
FR - Francia 7
TR - Turchia 6
AT - Austria 5
BE - Belgio 4
CH - Svizzera 4
UZ - Uzbekistan 4
CA - Canada 2
JP - Giappone 2
NL - Olanda 2
ZA - Sudafrica 2
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
EU - Europa 1
GR - Grecia 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
Totale 1.574
Città #
Dublin 166
Chandler 157
Hong Kong 92
Singapore 85
San Mateo 73
Jacksonville 60
Boardman 45
Altamura 42
Santa Clara 38
Medford 32
Princeton 32
Lawrence 31
Dong Ket 28
Beijing 26
Ann Arbor 25
Wilmington 24
Perugia 23
Andover 15
Saint Petersburg 12
Seoul 12
Dallas 11
Munich 10
Valencia 9
Dearborn 8
Izmir 6
Olomouc 6
Redmond 6
Los Angeles 5
Vienna 5
Brussels 4
Helsinki 4
Rome 4
Des Moines 3
San Paolo di Civitate 3
Amelia 2
Chicago 2
Collazzone 2
Deiva Marina 2
Genoa 2
Johannesburg 2
New York 2
Newton Stewart 2
Norwalk 2
Toronto 2
Woodbridge 2
Zhengzhou 2
Amsterdam 1
Ashburn 1
Athens 1
Auckland 1
Baku 1
Bruckmühl 1
Colombo 1
Den Haag 1
Falkenstein 1
Fuzhou 1
Gubbio 1
Hampton 1
Lappeenranta 1
London 1
Ludwigshafen 1
Milan 1
Nanning 1
Naucalpan 1
Newark 1
Philadelphia 1
Redwood City 1
San Diego 1
Santarcangelo di Romagna 1
Shanghai 1
Terni 1
Tokyo 1
Totale 1.152
Nome #
Diagnosis of platelet-type von Willebrand disease by flow cytometry. 75
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 74
Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. 67
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 67
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule. 65
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. 64
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 63
A new case of acquired Glanzmann's thrombasthenia: Diagnostic value of flow cytometry. 61
Comparative evaluation of the fully automated HemosIL®AcuStar ADAMTS13 activity assay vs. ELISA: Possible interference by autoantibodies different from anti ADAMTS-13 61
Incomplete inhibition of platelet function as assessed by the platelet function analyzer (PFA-100) identifies a subset of cardiovascular patients with high residual platelet response while on aspirin. 59
In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients. 56
Effect of First Long-Term Training on Whole Blood Count and Blood Clotting Parameters in Thoroughbreds 56
Established and new antiplatelet therapies 54
Possible role of platelet activation in the cardiovascular complications associated with HIV infection: differential effects of abacavir (ABC) vs. tenofovir (TDF) 53
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 49
Increase of von Willebrand factor with aging in type 1 von Willebrand disease: Fact or fiction? 49
Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry. 48
PAF levels in saliva are regulated by inflammatory cells 48
Involvement of platelets in experimental mouse trypanosomiasis: evidence of mouse platelet cytotoxicity against Trypanosoma equiperdum. 47
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin. 46
NCX4016: a novel antithrombotic agent. 46
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation 46
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage 46
Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugs 45
Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. 39
FVIII/VWF complex displays a greater pro-haemostatic activity than FVIII preparations devoid of VWF: Study in plasma and cell-based models 39
Role of platelet activation in the cardiovascular complications associated with HIV infection: differential effect of abacavir versus tenofovir 37
A p.Arg127Gln variant in GPIbα LRR5 allosterically enhances affinity for VWF: a novel form of platelet-type VWD 29
Platelet function assays in diagnosis: an update 28
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study. 26
The platelet count in EDTA-anticoagulated blood from patients with thrombocytopenia may be underestimated when measured in routine laboratories. 26
Usefulness of global tests of primary hemostasis in the initial screening of mild/moderate bleeding disorders for orienting towards von Willebrand disease or inherited platelet functions disorders 21
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway 21
Effect of Regular Training on Platelet Function in Untrained Thoroughbreds 18
Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity 15
Biomarkers of in vivo platelet activation in thoroughbreds during their first long-term training 11
Totale 1.655
Categoria #
all - tutte 8.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202097 0 0 0 0 0 6 18 4 23 37 4 5
2020/2021222 3 16 2 16 73 4 23 10 22 7 17 29
2021/2022223 5 56 4 6 5 0 2 72 5 5 28 35
2022/2023522 33 110 8 37 47 42 0 20 201 2 15 7
2023/2024236 8 17 12 8 3 0 46 8 49 9 43 33
2024/2025202 12 53 18 31 66 22 0 0 0 0 0 0
Totale 1.655